DK0814793T3 - Aerosolpræparater med prilocain og carbonhydridfluorid - Google Patents
Aerosolpræparater med prilocain og carbonhydridfluoridInfo
- Publication number
- DK0814793T3 DK0814793T3 DK96902844T DK96902844T DK0814793T3 DK 0814793 T3 DK0814793 T3 DK 0814793T3 DK 96902844 T DK96902844 T DK 96902844T DK 96902844 T DK96902844 T DK 96902844T DK 0814793 T3 DK0814793 T3 DK 0814793T3
- Authority
- DK
- Denmark
- Prior art keywords
- prilocaine
- hfc
- pharmaceutical
- propellants
- base
- Prior art date
Links
- MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 title abstract 7
- 239000000443 aerosol Substances 0.000 title abstract 3
- 229960001807 prilocaine Drugs 0.000 title abstract 3
- -1 hydrocarbon fluoride Chemical class 0.000 title abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 title 1
- 229930195733 hydrocarbon Natural products 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 239000003380 propellant Substances 0.000 abstract 3
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 abstract 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 abstract 2
- 229940088598 enzyme Drugs 0.000 abstract 2
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 abstract 1
- YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 abstract 1
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 abstract 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 abstract 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 abstract 1
- VTUSIVBDOCDNHS-UHFFFAOYSA-N Etidocaine Chemical compound CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C VTUSIVBDOCDNHS-UHFFFAOYSA-N 0.000 abstract 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 229960002749 aminolevulinic acid Drugs 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 229940064004 antiseptic throat preparations Drugs 0.000 abstract 1
- 229960005274 benzocaine Drugs 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 239000000168 bronchodilator agent Substances 0.000 abstract 1
- 229960003150 bupivacaine Drugs 0.000 abstract 1
- 229960002023 chloroprocaine Drugs 0.000 abstract 1
- VDANGULDQQJODZ-UHFFFAOYSA-N chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 abstract 1
- 229960003920 cocaine Drugs 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 239000000645 desinfectant Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229960003976 etidocaine Drugs 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229960004194 lidocaine Drugs 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 229960002409 mepivacaine Drugs 0.000 abstract 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960001802 phenylephrine Drugs 0.000 abstract 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 abstract 1
- 229960004919 procaine Drugs 0.000 abstract 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108091006082 receptor inhibitors Proteins 0.000 abstract 1
- 229960001549 ropivacaine Drugs 0.000 abstract 1
- 230000003381 solubilizing effect Effects 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 230000002227 vasoactive effect Effects 0.000 abstract 1
- 239000005526 vasoconstrictor agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/405,930 US5593661A (en) | 1993-03-29 | 1995-03-17 | Lidocaine aerosol anaesthetic |
| US08/408,877 US5534242A (en) | 1994-05-02 | 1995-03-24 | Lidocaine-vasoconstrictor aerosol preparation |
| US08/435,812 US5589156A (en) | 1994-05-02 | 1995-05-05 | Prilocaine and hydrofluourocarbon aerosol preparations |
| PCT/CA1996/000122 WO1996029066A1 (en) | 1995-03-17 | 1996-03-04 | Prilocaine and hydrofluorocarbon aerosol preparations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0814793T3 true DK0814793T3 (da) | 2003-12-01 |
Family
ID=27410659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96902844T DK0814793T3 (da) | 1995-03-17 | 1996-03-04 | Aerosolpræparater med prilocain og carbonhydridfluorid |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5589156A (da) |
| EP (1) | EP0814793B1 (da) |
| JP (1) | JP4117707B2 (da) |
| CN (1) | CN1149080C (da) |
| AT (1) | ATE245025T1 (da) |
| AU (1) | AU710600B2 (da) |
| BR (1) | BR9607988A (da) |
| DE (1) | DE69629109T2 (da) |
| DK (1) | DK0814793T3 (da) |
| ES (1) | ES2203676T3 (da) |
| LU (1) | LU92402I2 (da) |
| PT (1) | PT814793E (da) |
| WO (1) | WO1996029066A1 (da) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5593661A (en) * | 1993-03-29 | 1997-01-14 | Henry; Richard A. | Lidocaine aerosol anaesthetic |
| EP0759744B1 (en) * | 1994-05-13 | 2001-10-17 | Aradigm Corporation | Narcotic containing aerosol formulation |
| US6013245A (en) * | 1995-01-26 | 2000-01-11 | Glaxo Group Limited | Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant |
| US5955098A (en) * | 1996-04-12 | 1999-09-21 | Flemington Pharmaceutical Corp. | Buccal non polar spray or capsule |
| US5954688A (en) * | 1997-08-26 | 1999-09-21 | Queen's University At Kingston | Everting toroid device for delivering a drug into a body cavity |
| US6200288B1 (en) | 1997-08-26 | 2001-03-13 | Queen's University At Kingston | Everting toroid device for insertion into a body cavity |
| GB2332372B (en) * | 1997-12-08 | 2002-08-14 | Minnesota Mining & Mfg | Pharmaceutical aerosol compositions |
| US6423298B2 (en) | 1998-06-18 | 2002-07-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pharmaceutical formulations for aerosols with two or more active substances |
| DE19827178A1 (de) * | 1998-06-18 | 2000-04-27 | Boehringer Ingelheim Pharma | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen |
| EP1087750B1 (en) * | 1998-06-18 | 2003-11-12 | Boehringer Ingelheim Pharmaceuticals Inc. | Pharmaceutical formulations for aerosols with two or more active substances |
| US6235265B1 (en) | 1998-10-28 | 2001-05-22 | Alliedsignal Inc. | Evaporative coolant for topical anesthesia comprising hydrofluorocarbons and/or hydrochlorofluorocarbons |
| WO2001045678A2 (de) * | 1999-12-21 | 2001-06-28 | Id Pharma Gmbh | Arzneimittel, verfahren zu dessen herstellung und dessen verwendung |
| GB0015361D0 (en) * | 2000-06-22 | 2000-08-16 | Pharmasol Ltd | Improvements in pharmaceutical compositions |
| DE50211045D1 (de) * | 2001-03-30 | 2007-11-22 | Jagotec Ag | Medizinische aerosolformulierungen |
| US20040241103A1 (en) * | 2002-09-10 | 2004-12-02 | 3M Innovative Properties Company | Pharmaceutical aerosol compositions |
| US20040076671A1 (en) * | 2002-10-21 | 2004-04-22 | Aletha Tippett | Methods and compositions for topical wound treatment |
| US7785584B2 (en) * | 2003-08-13 | 2010-08-31 | Healthpoint, Ltd. | Ointment wound spray |
| US7105006B2 (en) * | 2003-08-15 | 2006-09-12 | Stat Medical Devices, Inc. | Adjustable lancet device and method |
| US20050123484A1 (en) * | 2003-10-02 | 2005-06-09 | Collegium Pharmaceutical, Inc. | Non-flammable topical anesthetic liquid aerosols |
| US20060188449A1 (en) * | 2003-10-03 | 2006-08-24 | Jane Hirsh | Topical aerosol foams |
| US20050255048A1 (en) * | 2004-05-15 | 2005-11-17 | Collegium Pharmaceutical, Inc. | Sprayable formulations for the treatment of acute inflammatory skin conditions |
| US20080019927A1 (en) * | 2004-06-07 | 2008-01-24 | Jie Zhang | Compositions and methods for dermally treating neuropathy with minoxidil |
| US20070196293A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Compositions and methods for treating photo damaged skin |
| US8741332B2 (en) * | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for dermally treating neuropathic pain |
| US20070189978A1 (en) * | 2004-06-07 | 2007-08-16 | Jie Zhang | Compositions and methods for dermally treating musculoskeletal pain |
| US20070196457A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs |
| US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
| US20070196323A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs |
| US20070189977A1 (en) * | 2004-06-07 | 2007-08-16 | Jie Zhang | Spray-on formulations and methods for dermal delivery of drugs |
| US20070196452A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Flux-enabling compositions and methods for dermal delivery of drugs |
| US20070190124A1 (en) * | 2004-06-07 | 2007-08-16 | Jie Zhang | Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs |
| US8741333B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for treating dermatitis or psoriasis |
| US20070280972A1 (en) * | 2006-04-25 | 2007-12-06 | Zars, Inc. | Adhesive solid gel-forming formulations for dermal drug delivery |
| US9265898B2 (en) * | 2007-09-12 | 2016-02-23 | Wolfe Tory Medical, Inc. | Applicator for oropharyngeal anesthetic |
| US20090093547A1 (en) * | 2007-10-09 | 2009-04-09 | Sciele Pharma, Inc. | Compositions and Methods for Treating Premature Ejaculation |
| FR2927256B1 (fr) * | 2008-02-13 | 2010-05-14 | Top Pharm Lab | Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation |
| US8652443B2 (en) * | 2008-02-14 | 2014-02-18 | Precision Dermatology, Inc. | Foamable microemulsion compositions for topical administration |
| CN102065694A (zh) * | 2008-04-15 | 2011-05-18 | 萨可德公司 | 用于局部治疗免疫相关疾病的雾化的lfa-1拮抗剂 |
| WO2010074753A1 (en) | 2008-12-23 | 2010-07-01 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
| CN102093248B (zh) * | 2010-12-22 | 2013-12-04 | 蚌埠丰原医药科技发展有限公司 | 一种制备盐酸丙胺卡因的方法 |
| US20130156823A1 (en) * | 2011-12-20 | 2013-06-20 | MAP Pharmacauticals, Inc. | Excipient-free Aerosol Formulation |
| US10149843B1 (en) | 2017-02-07 | 2018-12-11 | Gneus Lifescineces Inc. | Pharmaceutical compositions and methods of using the same |
| US10413505B1 (en) | 2017-02-07 | 2019-09-17 | Genus Lifesciences Inc. | Pharmaceutical compositions and methods of using the same |
| US10231961B1 (en) | 2017-02-07 | 2019-03-19 | Genus Lifesciences Inc. | Pharmaceutical compositions and methods of using the same |
| CN112274498B (zh) * | 2020-11-09 | 2021-09-07 | 北京中泰邦医药科技有限公司 | 一种复方利多卡因气雾剂及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5380754A (en) * | 1988-02-29 | 1995-01-10 | Virotex Corporation | Topical composition enhancing healing of viral lesions |
| US5225183A (en) * | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| GB8900267D0 (en) * | 1989-01-06 | 1989-03-08 | Riker Laboratories Inc | Narcotic analgesic formulations and apparatus containing same |
| US5276032A (en) * | 1989-12-28 | 1994-01-04 | King O Newton | Vision aid and anesthetic composition |
| US5118494A (en) * | 1990-03-23 | 1992-06-02 | Minnesota Mining And Manufacturing Company | Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
| US5190029A (en) * | 1991-02-14 | 1993-03-02 | Virginia Commonwealth University | Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
| GB9103302D0 (en) * | 1991-02-16 | 1991-04-03 | Smithkline Beecham Plc | Pharmaceutical formulations |
| US5510339A (en) * | 1993-02-02 | 1996-04-23 | Mayo Foundation For Medical Education And Research | Method for the treatment of bronchial asthma by administration of topical anesthetics |
| WO1994022422A1 (en) * | 1993-03-29 | 1994-10-13 | Henry Richard A | Lidocaine aerosol anaesthetic |
| US5453445A (en) * | 1994-05-02 | 1995-09-26 | Henry; Richard A. | Lidocaine-phenylephrine aerosol preparation |
-
1995
- 1995-05-05 US US08/435,812 patent/US5589156A/en not_active Expired - Lifetime
-
1996
- 1996-03-04 DK DK96902844T patent/DK0814793T3/da active
- 1996-03-04 ES ES96902844T patent/ES2203676T3/es not_active Expired - Lifetime
- 1996-03-04 AT AT96902844T patent/ATE245025T1/de active
- 1996-03-04 AU AU47113/96A patent/AU710600B2/en not_active Expired
- 1996-03-04 EP EP96902844A patent/EP0814793B1/en not_active Expired - Lifetime
- 1996-03-04 JP JP52792396A patent/JP4117707B2/ja not_active Expired - Lifetime
- 1996-03-04 BR BR9607988-6A patent/BR9607988A/pt active IP Right Grant
- 1996-03-04 DE DE69629109T patent/DE69629109T2/de not_active Expired - Lifetime
- 1996-03-04 PT PT96902844T patent/PT814793E/pt unknown
- 1996-03-04 WO PCT/CA1996/000122 patent/WO1996029066A1/en not_active Ceased
- 1996-03-04 CN CNB961926457A patent/CN1149080C/zh not_active Expired - Lifetime
-
2014
- 2014-03-18 LU LU92402C patent/LU92402I2/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0814793A1 (en) | 1998-01-07 |
| CN1149080C (zh) | 2004-05-12 |
| AU4711396A (en) | 1996-10-08 |
| JP4117707B2 (ja) | 2008-07-16 |
| JPH11502202A (ja) | 1999-02-23 |
| BR9607988A (pt) | 1999-11-30 |
| WO1996029066A1 (en) | 1996-09-26 |
| PT814793E (pt) | 2003-12-31 |
| MX9707073A (es) | 1998-08-30 |
| US5589156A (en) | 1996-12-31 |
| EP0814793B1 (en) | 2003-07-16 |
| ES2203676T3 (es) | 2004-04-16 |
| ATE245025T1 (de) | 2003-08-15 |
| AU710600B2 (en) | 1999-09-23 |
| CN1179103A (zh) | 1998-04-15 |
| LU92402I2 (fr) | 2014-05-19 |
| DE69629109T2 (de) | 2004-04-15 |
| DE69629109D1 (de) | 2003-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0814793T3 (da) | Aerosolpræparater med prilocain og carbonhydridfluorid | |
| DE60321774D1 (de) | Aerosol-formulierungen von formoterol und mometason | |
| JP2769925B2 (ja) | ベクロメタゾン１７，２１ジプロピオネートを含んで成るエアロゾル製剤 | |
| EA199900991A1 (ru) | Медицинские аэрозольные препараты | |
| AR038643A1 (es) | Formulaciones en aerosol para la administracion pulmonar de medicamentos que producen un efecto sistemico | |
| BR9805993A (pt) | Composição farmacêutica de aerosol. | |
| NO20030133D0 (no) | Ny aerosolformulering inneholdende et polart fluorert molekyl | |
| HUP0001094A2 (hu) | Eljárás naloxon és sói stabilizálására, és naloxont tartalmazó, stabilizált gyógyszerkészítmények | |
| BR9909394A (pt) | Composição de aerossol, composição farmacêutica, recipiente, dispositivo de inalação, processo para preparar uma composição de aerossol, mistura de um primeiro material particulado, e, processo para administrar um medicamento particulado | |
| BR9916829A (pt) | Formulações aerossóis farmacêuticas contendo fluoroalcanos, budesonida e formoterol | |
| UA27143C2 (uk) | Рідка фармацевтичhа композиція в формі аерозолю | |
| DK1280515T3 (da) | Farmaceutiske sammensætninger omfattende cannabis | |
| ATE401056T1 (de) | Formoterol und ciclesonid aerosol-formulierungen | |
| KR950030812A (ko) | 살충 혼합물 | |
| EA200801889A1 (ru) | Дозированные аэрозоли для введения в организм фармацевтических композиций | |
| FR2848454B1 (fr) | Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide | |
| NO953515D0 (no) | Farmasöytiske sammensetninger inneholdende paracetamol og L-cystein eller en forlöper derav | |
| MX9306356A (es) | Composicion refrigerante que incluye bis(difluoro metil)eter. | |
| HUP9702348A2 (hu) | Új, véralvadásgátló hatású glikozidok és az ezeket tartalmazó gyógyszerkészítmények | |
| ATE470669T1 (de) | D-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpregn 4-ene-20-yne-3-one in form des reinen 3e- und 3z- oximes sowie das verfahren zur herstellung der mischung der isomere wie auch der reinen isomere | |
| RU2217420C1 (ru) | 2-r-7а-метил-3-(спироциклогекса-2,5-диен-4-он)-пергидроиндолины-1 | |
| ITMI932767A1 (it) | Derivati policiclici di oxo-azasteroidi inibitori dell'enzima 5-alfa riduttasi, loro uso come antiandrogeni e composizioni farmaceutiche che li contengono | |
| RU94045946A (ru) | Фторированные производные 4-аминоандростадиенона, способ их получения, фармацевтическая композиция |